A Study of QLM2011 in Subjects With Advanced Solid Tumors

NCT06925659 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

172

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: QLM2011
DRUG: Taxotere®

Sponsor

Qilu Pharmaceutical (Hainan) Co., Ltd.